IP Library Granted Patent US 8,821,893
Granted Patent B2
US 8,821,893 · App. 11/631,090 · Granted Sep 2, 2014

Oral vaccine for

Inventors: Raymond J. Dattwyler (East Setauket, NY); Maria Gomes-Solecki (New York, NY)
Assignee: Bio Peptides, Corp.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,821,893
App. No.
11/631,090
Granted
Sep 2, 2014
Kind
B2
Abstract

The present invention relates to vaccines for control of Borrelia infections in animal and human populations. In particular, the present invention provides compositions and methods comprising recombinant bacteria engineered to express one or more Borrelia burgdorferi antigens for use as Lyme disease vaccines. In some embodiments, the recombinant bacteria are freeze-dried.

Claims (13)

1. A method of immunizing a subject comprising:

a) providing an oral vaccine composition comprising a lyophilized Escherichia coli , and Lactobacillus plantarum bacterium engineered to express a protein comprising a modified amino acid sequence set forth herein as SEQ ID NO:2, wherein said modified SEQ ID NO:2 comprises a deletion of hLFA1 epitope SEQ ID NO:5 (YVLEGTLTA), and

b) orally administering said oral vaccine composition to a subject under conditions suitable for eliciting an antibody response in said subject against a Borrelia burgdorferi outer surface protein.

2. The method of claim 1 , wherein said oral vaccine composition further comprises a food carrier or an excipient.

3. The method of claim 1 , wherein said subject is a mammal.

4. The method of claim 3 , wherein said mammal is a feral animal comprising one or more of a mouse, a chipmunk, a squirrel, a shrew, a vole, a rat, a raccoon, an opossum, a skunk, a rabbit, and a deer.

5. The method of claim 3 , wherein said mammal is a domesticated animal comprising one or more of a dog, a cat, a cow, and a horse.

6. The method of claim 1 , wherein said antibody response comprises an outer surface protein-reactive serum IgG titer of at least 1:100.

7. The method of claim 1 , wherein said orally administering comprises more than one meal.

8. The method of claim 1 , wherein said bacterium comprises a lactobacillus selected from the group consisting of L. acidophilus, L. brevis, L. casei, L. crispatus, L. fermentum, L. gasseri, L. plantarum, L. reuteri, L. rhamnosus , and L. salivarius.

9. The method of claim 2 , wherein said food carrier comprises a dairy product selected from the group consisting of milk, yogurt, and cheese, or a grain product selected from the group consisting of grain, seed, bread, and cereal.

10. The method of claim 2 , wherein said excipient is selected from the group consisting of a sugar, a starch, a gum, and a protein.

11. The method of claim 2 , wherein said food carrier comprises animal chow.

Assignments (3)
CONFIRMATORY LICENSE Recorded Sep 28, 2016
From: BIOPEPTIDES, INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 040166/0657 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2015
From: BIOPEPTIDES, CORP
To: US BIOLOGIC, INC.
Reel/Frame 036594/0069 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 30, 2010
From: DATTWYLER, RAYMOND; GOMES-SOLECKI, MARIA
To: BIOPEPTIDES, CORP.
Reel/Frame 025413/0094 →
Continuity (2)
Provisional Application 60585057 · Jul 2, 2004
Related Publication 20090297560A1 · Dec 3, 2009